Answers are grounded in this paper and cite their sources.
To clarify the possible role of Langerhans cells (LCs) in oral verrucous carcinoma (OVC), LCs and anti-tumor immune cells in OVCs were immunohistochemically investigated with the use of anti-CD1a, 3, 4, 8, 68, and 79α antibodies. In OVCs, mucosa adjacent to OVCs, and normal oral mucosa, most intraepithelial CD1a-positive LCs were located in parabasal regions. Subepithelial LCs were scatteredly throughout the lamina propria. The densities of intraepithelial and subepithelial CD1a-positive LCs in OVCs were significantly higher than those in adjacent mucosa or normal oral mucosa. The density of CD1a-positive LCs in T3 stage OVCs was slightly lower than those in T1 and T2 stage OVCs. The majority of infiltrating CD3-, CD4-, and CD8-positive T lymphocytes, CD79α-positive B lymphocytes, and CD68-positive macrophages were observed in subepithelial portions of OVCs, but scattered CD3-, CD4-, and CD8-positive T lymphocytes were observed in intraepithelial portions of OVCs. CD8-positive T lymphocytes were more numerous than CD4-positive T lymphocytes in subepithelial portions of OVCs. In mucosa adjacent to OVCs and in normal oral mucosa, infiltration by CD3-, CD4-, and CD8-positive T lymphocytes, CD79α-positive B lymphocytes, and CD68-positive macrophages was minimal in both intraepithelial and subepithelial regions. LCs were slightly more numerous in CD8-positive T-cell dominant OVCs than in CD4-positive T-cell dominant OVCs. These results suggest that CD1a-positive LCs are related to CD8-positive T lymphocytes and that CD1a-positive LCs play a role in the anti-tumor immune response in OVCs.
No takes yet. Share an insight, caveat, or question.
Izutsu et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: